• Profile
Close

Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: A meta-analysis

Infection and Drug Resistance Evidence based | Aug 15, 2017

Lau CSM, et al. – Authors performed this meta–analysis determining the impact of probiotic supplementation on the efficacy of standard triple therapy in eradicating H. pylori. Findings suggested a beneficial impact of probiotics addition regarding H. pylori eradication rates in both children and adults, as well as Asians and non–Asians. In addition, the reduction in antibiotic–associated side effects such as nausea, vomiting, diarrhea, and epigastric pain seemed improving medication tolerance and patient compliance. Given the consequences associated with chronic H. pylori infection, they suggest addition of probiotics to the concurrent triple therapy regimen in all patients with H. pylori infection. However, to identify the optimal probiotic species and dose, further studies were recommended.

Methods

  • Authors performed a comprehensive literature search using PubMed, Cochrane Central Registry of Controlled Trials, and Google Scholar (time of inception to 2016) to identify all published randomized control trials (RCTs) assessing the use of probiotics in addition to triple therapy for the treatment of H. pylori.
  • Keywords used for the search included: “probiotics”, “triple therapy”, and “Helicobacter pylori”.
  • They included RCTs comparing the use of probiotics and standard triple therapy with standard triple therapy alone for any duration in patients of any age diagnosed with H. pylori infection.
  • Analysis of H. pylori eradication rates (detected using urea breath test or stool antigen) was performed as–per–protocol (APP) and intention–to–treat (ITT).

Results

  • Analysis of 30 RCTs involving 4,302 patients APP and 4,515 patients ITT was performed.
  • Probiotics addition significantly increased eradication rates by 12.2% (relative risk [RR] =1.122; 95% confidence interval [CI], 1.091–1.153; P<0.001) APP and 14.1% (RR =1.141; 95% CI, 1.106–1.175; P<0.001) ITT.
  • Probiotics proved valuable among children and adults, as well as Asians and non–Asians.
  • There appeared no significant difference in efficacy between the various types of probiotics.
  • Reduction in the risk of diarrhea, nausea, vomiting, and epigastric pain was also observed.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay